###begin article-title 0
###xml 83 84 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 12 17 <span type="species:ncbi:10090">Mouse</span>
Recombinant Mouse PAP Has pH-Dependent Ectonucleotidase Activity and Acts through A1-Adenosine Receptors to Mediate Antinociception
###end article-title 0
###begin p 1
Conceived and designed the experiments: MJZ. Performed the experiments: NAS KIV. Analyzed the data: NAS MJZ. Contributed reagents/materials/analysis tools: MJZ. Wrote the paper: MJZ.
###end p 1
###begin p 2
###xml 267 268 267 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 290 291 290 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1050 1051 1050 1051 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 162 167 <span type="species:ncbi:9606">human</span>
###xml 172 178 <span type="species:ncbi:9913">bovine</span>
###xml 358 363 <span type="species:ncbi:10090">mouse</span>
###xml 957 960 <span type="species:ncbi:31658">CFA</span>
###xml 1202 1207 <span type="species:ncbi:9606">human</span>
###xml 1212 1218 <span type="species:ncbi:9913">bovine</span>
Prostatic acid phosphatase (PAP) is expressed in nociceptive neurons and functions as an ectonucleotidase. When injected intraspinally, the secretory isoforms of human and bovine PAP protein have potent and long-lasting antinociceptive effects that are dependent on A1-adenosine receptor (A1R) activation. In this study, we purified the secretory isoform of mouse (m)PAP using the baculovirus expression system to determine if recombinant mPAP also had antinociceptive properties. We found that mPAP dephosphorylated AMP, and to a much lesser extent, ADP at neutral pH (pH 7.0). In contrast, mPAP dephosphorylated all purine nucleotides (AMP, ADP, ATP) at an acidic pH (pH 5.6). The transmembrane isoform of mPAP had similar pH-dependent ectonucleotidase activity. A single intraspinal injection of mPAP protein had long-lasting (three day) antinociceptive properties, including antihyperalgesic and antiallodynic effects in the Complete Freund's Adjuvant (CFA) inflammatory pain model. These antinociceptive effects were transiently blocked by the A1R antagonist 8-cyclopentyl-1, 3-dipropylxanthine (CPX), suggesting mPAP dephosphorylates nucleotides to adenosine to mediate antinociception just like human and bovine PAP. Our studies indicate that PAP has species-conserved antinociceptive effects and has pH-dependent ectonucleotidase activity. The ability to metabolize nucleotides in a pH-dependent manner could be relevant to conditions like inflammation where tissue acidosis and nucleotide release occur. Lastly, our studies demonstrate that recombinant PAP protein can be used to treat chronic pain in animal models.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 188 191 188 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Dodd1">[1]</xref>
###xml 193 196 193 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-KnyiharCsillik1">[2]</xref>
###xml 312 315 312 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 398 401 398 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Vihko1">[4]</xref>
###xml 403 406 403 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Quintero1">[5]</xref>
###xml 408 411 408 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Roiko1">[6]</xref>
###xml 777 780 777 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 1029 1032 1029 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
Small-diameter dorsal root ganglia (DRG) neurons contain a classic, histochemically-defined enzyme known as Fluoride-Resistant Acid Phosphatase (FRAP) or Thiamine Monophosphatase (TMPase) [1], [2]. Recently, we found that TMPase was molecularly equivalent to Prostatic Acid Phosphatase (PAP, also known as ACPP) [3]. In mammals, PAP is expressed as a secreted protein or as a transmembrane protein [4], [5], [6]. These isoforms have identical N-terminal regions, including a signal peptide and extracellular acid phosphatase domain, but differ at the C-terminus due to the inclusion or exclusion of a transmembrane domain. Using in situ hybridization with isoform-specific riboprobes, we found that small-diameter DRG neurons primarily express the transmembrane isoform of PAP [3]. Moreover, using immunohistochemistry, we found that PAP protein is localized to a majority of all nonpeptidergic nociceptive neurons, a subset of peptidergic nociceptive neurons and to axon terminals located in lamina II of the dorsal spinal cord [3].
###end p 4
###begin p 5
###xml 144 147 144 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 363 364 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 386 387 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 401 404 401 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 624 625 624 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 668 671 668 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 665 671 665 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAP<sup>&#8722;/&#8722;</sup></italic>
###xml 773 776 773 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 811 812 811 812 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 813 816 813 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 810 816 810 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A<sub>1</sub>R<sup>&#8722;/&#8722;</sup></italic>
###xml 822 825 822 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Wu1">[7]</xref>
###xml 953 956 953 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 950 956 950 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAP<sup>&#8722;/&#8722;</sup></italic>
###xml 213 218 <span type="species:ncbi:9606">human</span>
###xml 540 546 <span type="species:ncbi:9913">bovine</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
###xml 817 821 <span type="species:ncbi:10090">mice</span>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
We also found that PAP functions in nociceptive circuits as an ectonucleotidase by dephosphorylating adenosine monophosphate (AMP) to adenosine [3]. This was based on our observation that intrathecal injection of human (h)PAP protein (the secreted isoform) produced long-lasting antinociceptive, antihyperalgesic and antiallodynic effects that were dependent on A1-adenosine receptor (A1R) activation [3]. These antinociceptive effects were eight-times more effective than the commonly used analgesic morphine. When injected intrathecally, bovine (b)PAP also had long-lasting antinociceptive effects that were dependent on A1R activation. Conversely, PAP knockout (PAP-/-) mice showed enhanced sensitivity in animal models of chronic inflammatory pain and neuropathic pain [3], a phenotype that was similar to A1R-/- mice [7]. Lastly, dephosphorylation of extracellular AMP was greatly reduced in small-diameter DRG neurons and dorsal spinal cord of PAP-/- mice.
###end p 5
###begin p 6
###xml 126 129 126 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 846 849 834 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Vihko2">[8]</xref>
###xml 851 854 839 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Ostanin1">[9]</xref>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 110 116 <span type="species:ncbi:9913">bovine</span>
###xml 157 162 <span type="species:ncbi:9606">human</span>
###xml 164 170 <span type="species:ncbi:9913">bovine</span>
###xml 175 180 <span type="species:ncbi:10090">mouse</span>
###xml 794 799 <span type="species:ncbi:9606">human</span>
###xml 804 807 <span type="species:ncbi:10116">rat</span>
For our initial study, we used secretory isoforms of PAP that were purified from human seminal fluid and from bovine prostate [3]. The secretory isoforms of human, bovine and mouse PAP are approximately80% identical to one another at the amino acid level (based on pairwise sequence comparisons), suggesting they might have similar antinociceptive effects in vivo. At the time we performed our initial studies, we were unable to test mPAP protein for antinociceptive effects because there were no commercially available sources of pure mPAP protein. Moreover, without pure protein, we could not determine the substrate specificity for secretory mPAP. To overcome these limitations, we synthesized and purified recombinant mPAP protein (secretory isoform). Strategies for generating recombinant human and rat PAP protein were previously described [8], [9]. At neutral pH, mPAP primarily dephosphorylated AMP. In addition, we found that mPAP could dephosphorylate all purine nucleotides (AMP, ADP, ATP) under acidic pH conditions. This suggested a broader function for PAP in nucleotide metabolism and has implications in inflammatory pain conditions where extracellular pH is reduced.
###end p 6
###begin p 7
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Burch1">[10]</xref>
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Dorr1">[11]</xref>
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zucchini1">[12]</xref>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 132 138 <span type="species:ncbi:9606">humans</span>
###xml 246 251 <span type="species:ncbi:10090">mouse</span>
###xml 255 260 <span type="species:ncbi:9606">human</span>
###xml 300 306 <span type="species:ncbi:9606">humans</span>
Recombinant proteins can be produced in large quantities, are not likely to be contaminated with human pathogens and can be used in humans [10], [11], [12]. Thus, the approaches outlined in this study could be used to purify and test recombinant mouse or human PAP as a treatment for chronic pain in humans.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
Purification of recombinant mPAP using the baculovirus expression system
###end title 9
###begin p 10
###xml 129 132 129 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Vihko2">[8]</xref>
###xml 134 137 134 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Ostanin1">[9]</xref>
###xml 355 356 355 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 371 381 371 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g001">Fig. 1A, B</xref>
###xml 471 478 471 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g001">Fig. 1B</xref>
###xml 554 555 554 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 41 44 <span type="species:ncbi:10116">rat</span>
###xml 89 94 <span type="species:ncbi:4932">yeast</span>
Large quantities of recombinant human or rat PAP (secretory isoform) can be generated in yeast or baculovirus expression systems [8], [9]. We generated a baculovirus expression construct containing the entire open-reading frame of secretory mPAP, encompassing the signal peptide (SP) and catalytic domain fused to a C-terminal thrombin-hexahistidine (Tr-H6) epitope tag (Fig. 1A, B). Although the thrombin cleavage site can be used to efficiently remove the epitope tag (Fig. 1B, data not shown), we performed our studies below with recombinant mPAP-Tr-H6 (henceforth referred to as mPAP) containing the C-terminal epitope tag because removal of the tag required additional purification steps and did not impact enzyme activity.
###end p 10
###begin title 11
Purification of recombinant mPAP.
###end title 11
###begin p 12
###xml 66 67 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 284 285 284 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
(A) A thrombin cleavage site (Tr) followed by hexahistidine tag (H6) and stop codon (*) were added to the C-terminus of the secretory isoform of mPAP. SP = signal peptide of mPAP. Map is not drawn to scale. (B) Amino acid sequence at the junction between the catalytic domain and Tr-H6 tag. Arrow marks thrombin cleavage site. Asterisk marks stop codon. (C) GelCode blue-stained SDS-PAGE gel and (D) western blot of purified recombinant mPAP protein (1 microg and 5 microg, respectively). The western blot was probed with an anti-hexahistidine antibody.
###end p 12
###begin p 13
###xml 346 353 346 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g001">Fig. 1C</xref>
###xml 377 384 377 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g001">Fig. 1D</xref>
###xml 719 723 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Ostrowski1">[13]</xref>
###xml 725 729 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Schneider1">[14]</xref>
###xml 1095 1097 1071 1073 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1109 1115 1085 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g002">Fig. 2</xref>
###xml 1190 1193 1166 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Vihko2">[8]</xref>
###xml 1195 1198 1171 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Ostanin1">[9]</xref>
###xml 1200 1204 1176 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Porvari1">[15]</xref>
###xml 1130 1135 <span type="species:ncbi:9606">human</span>
###xml 1140 1143 <span type="species:ncbi:10116">rat</span>
We detected large quantities of mPAP protein in the tissue culture supernatant of Hi5 insect cells two days after infection with recombinant baculovirus. We purified mPAP from the supernatant in one step, using nickel chelate affinity chromatography. We confirmed protein purity by running mPAP on an SDS-PAGE gel and staining for total protein (Fig. 1C) and western blotting (Fig. 1D). In both cases, we observed one predominant band at approximately45 kDa, corresponding to the calculated molecular weight of monomeric mPAP (45.2 kDa). The weakly stained approximately90 kDa band on our overloaded western blot likely reflects a small amount of non-denatured mPAP, consistent with the fact that native PAP is a dimer [13], [14]. No additional bands were observed, indicating that mPAP protein was pure and largely intact. This purified, recombinant mPAP protein effectively dephosphorylated the generic acid phosphatase substrates para-nitrophenyl phosphate (p-NPP) and 6,8-difluoro-4-methylumbelliferyl phosphate (DiFMUP) and was inhibited by the acid phosphatase inhibitor L-(+)-tartrate (IC50 = 1.45 mM; Fig. 2). Recombinant human and rat PAP are similarly inhibited by L-(+)-tartrate [8], [9], [15].
###end p 13
###begin title 14
Inhibition of mPAP by L-(+)-tartrate.
###end title 14
###begin p 15
The indicated concentrations of L-(+)-tartrate were added to reactions (n = 3 per concentration) containing mPAP (1 U/mL), 100 mM sodium acetate, pH 5.6 and the fluorescent acid phosphatase substrate DiFMUP. Relative fluorescence units (RFU). All data are presented as means+/-s.e.m. Prism 5.0 (GraphPad Software, Inc) was used to generate curve.
###end p 15
###begin title 16
Recombinant mPAP dephosphorylates purine nucleotides in a pH-dependent manner
###end title 16
###begin p 17
###xml 142 145 142 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 454 461 454 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g003">Fig. 3A</xref>
###xml 513 516 513 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 593 600 593 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g003">Fig. 3B</xref>
###xml 780 784 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Vihko3">[16]</xref>
###xml 347 356 <span type="species:ncbi:64457">malachite</span>
We previously found that hPAP (secreted isoform) generated adenosine by dephosphorylating AMP and, to a much lesser extent, ADP at neutral pH [3]. To determine if secretory mPAP had similar substrate specificity and to evaluate pH dependence, we incubated mPAP with AMP, ADP or ATP at pH 7.0 or pH 5.6, then detected inorganic phosphate using the malachite green assay. We found that mPAP dephosphorylated AMP and, to a lesser extent, ADP at neutral pH (Fig. 3A), consistent with our previous findings using hPAP [3]. At pH 5.6, mPAP dephosphorylated AMP and ADP, and to a lesser extent, ATP (Fig. 3B). This latter finding was consistent with a previous study showing that secretory hPAP could dephosphorylate all nucleotides under acidic conditions with a rank order AMP>ADP>ATP [16].
###end p 17
###begin title 18
mPAP dephosphorylates purine nucleotides in a pH-dependent manner.
###end title 18
###begin p 19
###xml 200 209 <span type="species:ncbi:64457">malachite</span>
Plot of initial velocity at the indicated concentrations of AMP, ADP and ATP at (A) pH 7.0 and (B) pH 5.6. Reactions (n = 3 per point) were stopped after 3 min. Inorganic phosphate was measured using malachite green. All data are presented as means+/-s.e.m. Error bars are obscured due to their small size.
###end p 19
###begin p 20
###xml 202 205 202 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 785 794 785 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g004">Fig. 4A&#8211;C</xref>
###xml 911 920 911 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g004">Fig. 4D&#8211;F</xref>
###xml 1049 1058 1049 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g004">Fig. 4G&#8211;L</xref>
###xml 1377 1380 1377 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
###xml 440 445 <span type="species:ncbi:10090">mouse</span>
We previously found that the transmembrane isoform of mouse PAP (TM-PAP) could dephosphorylate extracellular AMP at pH 5.6 using enzyme histochemistry, indicating that PAP had ectonucleotidase activity [3]. At the time, we did not test hydrolysis at neutral pH or hydrolysis of other nucleotides. To determine if TM-PAP could dephosphorylate additional nucleotides extracellularly, and if dephosphorylation was pH dependent, we transfected mouse TM-PAP into HEK 293 cells and stained non-permeabilized cells using enzyme histochemistry. Use of non-permeabilized cells allowed us to measure extracellular nucleotide hydrolysis in a cellular context. At pH 7.0, TM-PAP transfected cells were heavily stained using AMP as substrate and much less intensely stained using ADP as substrate (Fig. 4A-C). At pH 5.6, TM-PAP transfected cells were heavily stained using AMP and moderately stained using ADP as substrate (Fig. 4D-F). Control cells transfected with the fluorescent protein Venus were not intensely stained under any of the conditions examined (Fig. 4G-L). When taken together, these data suggest TM-PAP has pH-dependent ectonucleotidase activity, with AMP being the preferred substrate at neutral pH and AMP and ADP being substrates at acidic pH. Moreover, these data suggest PAP could generate adenosine following hydrolysis of AMP, ADP or ATP under acidic pH conditions [3].
###end p 20
###begin title 21
TM-PAP dephosphorylates extracellular purine nucleotides in a pH-dependent manner.
###end title 21
###begin p 22
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
HEK 293 cells were transfected with expression vectors containing (A-F) mouse TM-PAP or (G-L) the fluorescent protein Venus as a control. Cells were then histochemically stained using AMP, ADP or ATP (each 6 mM) as substrate at pH 7.0 or pH 5.6. Cells were not permeabilized with detergent. Scale bar (bottom right panel), 50 microm for all panels.
###end p 22
###begin title 23
Recombinant mPAP has long-lasting antinociceptive properties
###end title 23
###begin p 24
###xml 155 158 155 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 320 326 320 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g005">Fig. 5</xref>
###xml 703 710 703 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g005">Fig. 5A</xref>
###xml 865 872 865 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g005">Fig. 5A</xref>
###xml 925 932 925 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g005">Fig. 5B</xref>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
A single intrathecal injection of hPAP protein (secreted isoform) has antinociceptive, antihyperalgesic and antiallodynic effects that last for three days [3]. To determine if mPAP also had long-lasting antinociceptive effects, we intrathecally (i.t.) injected wild-type mice with two doses of recombinant mPAP protein (Fig. 5). Control mice were injected i.t. with heat-denatured, and hence phosphatase-inactive, mPAP. We then measured noxious thermal and mechanical sensitivity before (baseline, BL) and after mPAP injections. Six hours after i.t. injection, paw withdrawal latency to the noxious thermal stimulus was significantly increased relative to controls and remained elevated for three days (Fig. 5A). This antinociceptive effect was dose-dependent and required catalytic activity, as evidenced by loss of antinociception upon heat-inactivation of mPAP (Fig. 5A). Active mPAP did not alter mechanical sensitivity (Fig. 5B) nor did it cause paralysis or sedation.
###end p 24
###begin title 25
Dose-dependent antinociceptive effects of intrathecal mPAP.
###end title 25
###begin p 26
###xml 473 474 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 659 660 655 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 672 673 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
(A) Effects of increasing amounts of mPAP on paw withdrawal latency to a radiant heat source. (B) Paw withdrawal threshold to a semi-flexible tip mounted on an electronic von Frey apparatus. (A, B) BL = Baseline. Injection (i.t.) volume was 5 microL. n = 8 wild-type mice were used per dose. There were significant differences over time between mice injected with heat-inactivated (0 U) mPAP and mice injected with active (1 U or 2 U) mPAP (Repeated measure two-way ANOVA; P<0.0001 for each dose). Post-hoc paired t-tests were used to compare responses at each time point between mice injected with active mPAP to mice injected with heat-inactivated mPAP (** P<0.005; *** P<0.0005). For the heat-inactivated mPAP control, the protein concentration was equivalent to the maximum 2 U dose of mPAP (1.1 mg/mL). All data are presented as means+/-s.e.m.
###end p 26
###begin p 27
###xml 401 408 401 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g006">Fig. 6A</xref>
###xml 577 584 577 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g006">Fig. 6A</xref>
###xml 665 672 665 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g005">Fig. 5A</xref>
###xml 847 854 847 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g006">Fig. 6B</xref>
###xml 77 80 <span type="species:ncbi:31658">CFA</span>
###xml 130 133 <span type="species:ncbi:31658">CFA</span>
We next tested mPAP for antihyperalgesic and antiallodynic effects using the CFA inflammatory pain model. To do this, we injected CFA into one hindpaw to induce inflammation and used the non-inflamed paw as a control. Intrathecal injection of mPAP produced a significant increase in withdrawal latency to the noxious thermal stimulus (relative to latency on Day 1, pre-injection) in the inflamed paw (Fig. 6A, white open circles). This antihyperalgesic effect persisted for three days. mPAP also caused a significant increase in paw withdrawal latency in the non-inflamed paw (Fig. 6A, grey open circles, relative to day 1 values), reproducing results presented in Fig. 5A. In addition, mPAP produced a significant increase in withdrawal threshold to the mechanical stimulus (relative to latency on Day 1, pre-injection) only in the inflamed paw (Fig. 6B, white open circles). This antiallodynic effect lasted for three days.
###end p 27
###begin title 28
###xml 83 84 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
The antinociceptive effects of mPAP can be transiently inhibited with a selective A1R antagonist.
###end title 28
###begin p 29
###xml 706 707 706 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 872 873 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 131 134 <span type="species:ncbi:31658">CFA</span>
###xml 136 139 <span type="species:ncbi:31658">CFA</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
Wild-type mice were tested for (A) noxious thermal and (B) mechanical sensitivity before (baseline, BL) and following injection of CFA (CFA-arrow) into one hindpaw. The non-inflamed hindpaw served as control. All mice were injected with active mPAP (mPAP-arrow; 2 U, i.t.). Two days later, half the mice were injected with vehicle (CPX/V-arrow, circles; intraperitoneal (i.p.); 1 hr before behavioral measurements) while the other half were injected with 8-cyclopentyl-1, 3-dipropylxanthine (CPX/V-arrow, squares; 1 mg/kg i.p.; 1 hr before behavioral measurements). There were significant differences over time between mice injected with vehicle and mice injected with CPX (Repeated measure two-way ANOVA; P<0.01). Post-hoc paired t-tests were used to compare responses at each time point between vehicle (n = 10) and CPX-injected mice (n = 10); same paw comparisons. *** P<0.0005. All data are presented as means+/-s.e.m.
###end p 29
###begin title 30
###xml 19 20 19 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
mPAP acts through A1Rs to mediate antinociception
###end title 30
###begin p 31
###xml 90 91 90 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 104 107 104 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 308 309 308 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 403 404 403 404 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 571 578 571 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g006">Fig. 6A</xref>
###xml 599 606 599 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g006">Fig. 6B</xref>
###xml 796 799 796 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 968 969 968 969 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 365 368 <span type="species:ncbi:31658">CFA</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 711 714 <span type="species:ncbi:31658">CFA</span>
The antinociceptive, antihyperalgesic and antiallodynic effects of hPAP are dependent on A1R activation [3]. Since our biochemical experiments suggested that mPAP could generate adenosine by dephosphorylating nucleotides, we next evaluated whether mPAP had antinociceptive properties that were dependent on A1R activation. To do this, we injected a second group of CFA-inflamed mice with the selective A1R antagonist 8-cyclopentyl-1, 3-dipropylxanthine (CPX; 1 mg/kg i.p.). CPX transiently antagonized all antinociceptive effects of mPAP, including the antihyperalgesic (Fig. 6A) and antiallodynic (Fig. 6B) effects. This same i.p. dose of CPX did not affect thermal or mechanical sensitivity in the control or CFA-inflamed paw once the antinociceptive effects of PAP wore off (see Figure S10 in [3]). Taken together, these data suggest that the antinociceptive effects of mPAP were due to ectonucleotidase-dependent generation of adenosine followed by activation of A1Rs.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 212 213 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 226 229 226 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
We previously found that PAP was expressed in nociceptive neurons and functioned as an ectonucleotidase by dephosphorylating AMP to adenosine. Moreover, PAP had antinociceptive properties that were dependent on A1R activation [3]. At the time, we could not perform in vivo gain-of-function studies with mPAP because there were no commercially available sources of secretory mPAP protein. To overcome this limitation, we generated and purified recombinant mPAP protein and then studied the biochemical properties of mPAP and the effects of mPAP on pain sensitivity.
###end p 33
###begin p 34
###xml 150 153 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Vihko2">[8]</xref>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Ostrowski1">[13]</xref>
###xml 213 219 213 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g002">Fig. 2</xref>
###xml 276 282 276 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g003">Fig 3A</xref>
###xml 284 287 284 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 389 396 389 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g003">Fig. 3B</xref>
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Vihko3">[16]</xref>
###xml 563 567 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-DziemborGryszkiewicz1">[17]</xref>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Dziembor1">[18]</xref>
###xml 575 579 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Lam1">[19]</xref>
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 581 586 <span type="species:ncbi:10090">Mouse</span>
Our studies revealed that recombinant mPAP has very similar biochemical properties when compared to PAP from other mammalian species, including human [8], [13]. Both mPAP and hPAP are inhibited by L-(+)-tartrate (Fig. 2), both predominantly dephosphorylate AMP at neutral pH (Fig 3A; [3]) and both dephosphorylate all adenine nucleotides (with relative activity AMP>ADP>ATP) at acidic pH (Fig. 3B) [16]. The Km values (0.9-1.6 mM) we obtained for mPAP using AMP as substrate were within the range of Km values (0.37-2 mM) reported for hPAP using AMP as substrate [17], [18], [19]. Mouse TM-PAP also dephosphorylated extracellular adenine nucleotides in a pH-dependent manner, although ATP was not a substrate for TM-PAP as it was for secretory PAP. This substrate discrepancy could reflect biochemical differences between these isoforms. Or, more likely, this reflects reduced sensitivity of the histochemical assay relative to the in vitro enzyme assay. When taken together, our findings suggest PAP functions as an ecto-5'-nucleotidase (with relative selectivity for AMP) at neutral pH and as a generic ectonucleotidase (with selectivity for AMP, ADP and ATP) at acidic pH.
###end p 34
###begin p 35
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Julius1">[20]</xref>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Caterina1">[21]</xref>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Waldmann1">[22]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Wemmie1">[23]</xref>
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Burnstock1">[24]</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Stucky1">[25]</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Burnstock1">[24]</xref>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Sawynok1">[26]</xref>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Tsuda1">[27]</xref>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-TozakiSaitoh1">[28]</xref>
###xml 578 582 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Nakagawa1">[29]</xref>
###xml 684 685 684 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 711 714 711 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 788 791 788 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 1035 1038 1035 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1032 1038 1032 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAP<sup>&#8722;/&#8722;</sup></italic>
###xml 1127 1130 1127 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 705 710 <span type="species:ncbi:10090">mouse</span>
###xml 1039 1043 <span type="species:ncbi:10090">mice</span>
This pH-dependent hydrolysis of purine nucleotides is intriguing, especially when considering that tissue injury produces an "inflammatory soup" containing protons and nucleotides [20]. Protons produce tissue acidosis, modulate the capsaicin receptor TRPV1 and activate acid-sensing ion channels (ASICs) half-maximally at pH values ranging from 4.9 to 6.8 [21], [22], [23]. ATP and ADP activate purinergic P2X and P2Y receptors [24], [25]. Stimulation of these diverse receptors sensitizes nociceptive neurons, activates spinal microglia and causes pain [24], [26], [27], [28], [29]. PAP is extensively co-localized with the ATP receptor P2X3 and is co-localized in 14.4% of all TRPV1+ DRG neurons in the mouse [3]. Since PAP protein is localized on peripheral terminals of these neurons [3] and can dephosphorylate adenine nucleotides at acidic pH, PAP could metabolize pain-producing ATP and ADP in the inflammatory soup and reduce the subsequent sensitization of nociceptive neurons. This is consistent with our observation that PAP-/- mice show enhanced thermal hyperalgesia and mechanical allodynia following inflammation [3].
###end p 35
###begin p 36
###xml 78 81 78 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 215 219 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Miesenbock1">[30]</xref>
###xml 308 312 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Wemmie1">[23]</xref>
###xml 499 503 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Sykova1">[31]</xref>
###xml 505 509 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Sykova2">[32]</xref>
###xml 511 515 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Chesler1">[33]</xref>
In addition, PAP is localized on the central terminals of nociceptive neurons [3] and could metabolize nucleotides to adenosine in a pH-dependent manner at central synapses. The pH of synaptic vesicles is 5.6+/-0.7 [30] and intense neural activity can lead to acidosis within synapses that lasts for seconds [23]. Likewise, inflammation, tissue injury and repetitive stimulation cause acidosis of up to 0.25 pH units in the dorsal horn of spinal cord when measured with pH-sensitive microelectrodes [31], [32], [33]. Considering the size of these microelectrodes relative to the small volume of a synapse, these microelectrode recordings likely underestimate the magnitude of the pH change that occurs within the confines of a synapse. Thus, PAP may be exposed to low extracellular or endosomal pH when spinal synapses are activated for sustained periods of time.
###end p 36
###begin p 37
###xml 179 185 179 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g005">Fig. 5</xref>
###xml 259 265 259 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g006">Fig. 6</xref>
###xml 374 377 374 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 435 436 435 436 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 237 240 <span type="species:ncbi:31658">CFA</span>
###xml 693 698 <span type="species:ncbi:9606">human</span>
###xml 700 706 <span type="species:ncbi:9913">bovine</span>
###xml 711 716 <span type="species:ncbi:10090">mouse</span>
Intrathecal injection of mPAP produced dose-dependent, potent and long-lasting (3 days) antihyperalgesic effects that were specific for the thermal modality in uninjured animals (Fig. 5) and antihyperalgesic and antiallodynic effects in CFA-inflamed animals (Fig. 6). Likewise, hPAP and bPAP had similar antinociceptive effects lasting three days and two days, respectively [3]. And, just like hPAP and bPAP mediated antinociception, A1R receptor activation was required for mPAP mediated antinociception. When combined with our biochemical results, this suggests that mPAP converts extracellular nucleotides to adenosine in vivo. Moreover, these data suggest a species-conserved function for human, bovine and mouse PAP as an ectonucleotidase.
###end p 37
###begin p 38
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Sawynok1">[26]</xref>
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Hayashida1">[34]</xref>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Lavandhomme1">[35]</xref>
###xml 204 205 204 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Belfrage1">[36]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Eisenach1">[37]</xref>
###xml 387 391 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Sawynok1">[26]</xref>
###xml 454 455 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Reppert1">[38]</xref>
###xml 115 121 <span type="species:ncbi:9606">humans</span>
Adenosine and A1R agonists have potent and, in some studies, long-lasting (>24 h) analgesic effects in rodents and humans when injected peripherally or centrally [26], [34], [35]. However, adenosine and A1R agonists are not used clinically to treat chronic pain because of side-effects, including transient lower back pain [36], [37], and motor paralysis when administered at high doses [26]. Motor side-effects could be due to widespread expression of A1R throughout the spinal cord, including relatively high-level expression in motor neurons [38].
###end p 38
###begin p 39
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 144 151 144 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g005">Figs. 5</xref>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g006">6</xref>
###xml 156 159 156 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
We did not observe motor paralysis at the highest doses of mouse and human PAP tested, despite the fact that PAP also works via A1R activation (Figs. 5, 6) [3]. This could be due to the fact that, as an enzyme, the amount of adenosine produced by PAP is limited by substrate concentration. Thus, through catalytic restriction, PAP may produce sufficient amounts of adenosine to mediate antinociception but not enough adenosine to cause overt motor side-effects.
###end p 39
###begin p 40
###xml 61 65 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-RodriguezNunez1">[39]</xref>
###xml 458 462 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Holton1">[40]</xref>
###xml 464 468 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Tsuda2">[41]</xref>
###xml 40 46 <span type="species:ncbi:9606">humans</span>
The resting CSF concentration of AMP in humans is 1.8 microM [39], well below the Km of mPAP and hPAP for AMP. Since this AMP concentration is below Km, PAP could produce linear increases in adenosine as the extracellular AMP concentration increases. This would allow PAP to dynamically generate adenosine over a wide range of nucleotide concentrations. This could be relevant in chronic pain states where extracellular nucleotides are likely to be elevated [40], [41].
###end p 40
###begin p 41
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Dorr1">[11]</xref>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zucchini1">[12]</xref>
###xml 350 351 350 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 432 442 432 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">indirectly</italic>
###xml 681 685 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Keil1">[42]</xref>
###xml 687 691 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Poon1">[43]</xref>
###xml 693 697 693 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Poon2">[44]</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Jarvis1">[45]</xref>
###xml 771 774 771 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Ostanin1">[9]</xref>
###xml 932 936 932 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Burch1">[10]</xref>
###xml 938 942 938 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Burch2">[46]</xref>
###xml 1225 1228 1225 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Ostanin1">[9]</xref>
###xml 1230 1234 1230 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Schneider1">[14]</xref>
###xml 1236 1240 1236 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Porvari1">[15]</xref>
###xml 1242 1246 1242 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Jakob1">[47]</xref>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 925 931 <span type="species:ncbi:9606">humans</span>
Recombinant proteins, such as human growth hormone and interferons, are routinely used to treat a variety of human diseases and disorders [11], [12]. We found that recombinant mPAP protein functions as a pH-dependent ectonucleotidase and has antinociceptive effects in an animal model of inflammatory pain. Unlike direct injections of adenosine and A1R agonists which produce antinociception and motor side effects, mPAP injections indirectly elevate adenosine levels and produce antinociception without side-effects. Interestingly, other methods that indirectly elevate adenosine, such as using adenosine kinase inhibitors, also produce antinociception without motor side effects [42], [43], [44], [45]. Considering how readily recombinant mPAP and hPAP can be purified [9], and the fact that recombinant hPAP (fused to GM-CSF; also known as PA2024, a component of the Provenge/Sipuleucel-T immunotherapy) is safe to use in humans [10], [46], recombinant PAP could be developed as a protein-based therapeutic for chronic pain. Moreover, it might be possible to further optimize PAP stability and kinetic parameters for therapeutic purposes, using site-directed mutagenesis and the PAP three-dimensional structure as a guide [9], [14], [15], [47].
###end p 41
###begin title 42
Materials and Methods
###end title 42
###begin title 43
Molecular biology and protein purification
###end title 43
###begin p 44
###xml 17 18 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 427 433 427 433 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tctaga</underline>
###xml 421 455 421 455 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-cgc<underline>tctaga</underline>accatgcgagccgttcctctgc</named-content>
###xml 482 483 482 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 502 508 502 508 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tctaga</underline>
###xml 496 567 496 567 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-gcg<underline>tctaga</underline>ttaatgatgatgatgatgatgggagccacgcggaaccagattccgtccttggtggctgc</named-content>
###xml 1765 1768 1759 1762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Vihko2">[8]</xref>
###xml 1363 1366 <span type="species:ncbi:9685">Cat</span>
###xml 1431 1434 <span type="species:ncbi:9685">Cat</span>
###xml 1576 1579 <span type="species:ncbi:9685">Cat</span>
###xml 1692 1695 <span type="species:ncbi:10116">rat</span>
The mPAP-Tr-(His)6 baculovirus expression clone (encompassing nt 61-1206 from GenBank accession # NM_019807) was generated by PCR amplification, using a full-length expression construct of mPAP (secreted isoform) as template and Phusion polymerase. PCR products were cloned into pFastBac1 (Invitrogen) and completely sequenced. Primer sequences contained XbaI sites (underlined) to facilitate cloning (N-terminal primer: 5'-cgctctagaaccatgcgagccgttcctctgc. C-terminal thrombin-(His)6 tag primer: 5'-gcgtctagattaatgatgatgatgatgatgggagccacgcggaaccagattccgtccttggtggctgc). There are no thrombin cleavage sites in the mPAP protein except for the cleavage site we introduced. This vector was then used to generate recombinant mPAP protein using the Bac-to-Bac Baculovirus Expression System (Invitrogen). Briefly, we infected Hi5 insect cells with high-titer recombinant baculovirus, incubated the cells for 48 hours at 27degreesC, then harvested and concentrated the supernatant containing secreted mPAP protein. Then, mPAP protein was purified from the concentrated supernatant using Ni-NTA HisTrap agarose (GE Healthcare Life Sciences) affinity chromatography and imidazole as eluant. Lastly, mPAP protein was dialyzed against PBS to remove imidazole. Protein purity was confirmed by SDS-PAGE, staining for total protein with GelCode Blue (Pierce/Thermo Scientific, Cat. # 24590) and western blotting with Penta-His antibody (Qiagen, Cat. # 34660). Amersham full-range rainbow molecular weight markers (GE Healthcare) were used for SDS-PAGE and MagicMark XP markers (Invitrogen, Cat. # LC5602) were used for western blots. This purification strategy is based on the observation that recombinant rat PAP is secreted into the medium of baculovirus-infected insect cells [8]. Recombinant mPAP was kept at 4degreesC for short-term (1-2 months) use and at -80degreesC for long-term storage.
###end p 44
###begin title 45
Enzyme assays
###end title 45
###begin p 46
###xml 495 498 481 484 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">650</sub>
###xml 542 543 528 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 545 546 531 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 563 567 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Lanzetta1">[48]</xref>
###xml 246 255 <span type="species:ncbi:64457">malachite</span>
###xml 289 298 <span type="species:ncbi:64457">malachite</span>
Enzymatic reactions (50 microL final) were carried out with recombinant mPAP at 37degreesC for 3 minutes in 10 mM sodium acetate, pH 5.6 or 10 mM HEPES, pH 7.0 with AMP, ADP or ATP as substrate. Reactions were stopped by adding 950 microL of the malachite green color reagent [0.03% (w/v) malachite green oxalate, 0.2% (w/v) sodium molybdate, 0.05% (v/v) Triton X-100, dissolved in 0.7 M HCl] then incubating at room temperature for 30 minutes. Inorganic phosphate was quantified by measuring OD650 and comparing to an inorganic phosphate (KH2PO4) standard curve [48].
###end p 46
###begin p 47
Enzyme activity of mPAP was determined using 4-nitrophenyl phosphate as substrate following Sigma's Quality Control Test Procedure for PAP (SSPNPP11, revision 8/29/97). Unit (U) definition: 1 U hydrolyzes 1 micromole of 4-nitrophenyl phosphate per minute at 37degreesC at pH 4.8.
###end p 47
###begin title 48
Cell culture and histochemistry
###end title 48
###begin p 49
###xml 68 71 68 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
###xml 133 136 133 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Zylka1">[3]</xref>
HEK 293 cells were cultured and transfected as previously described [3]. Enzyme histochemistry was performed as previously described [3] using 6 mM AMP, ADP, or ATP as substrate and Tris-maleate buffer at pH 5.6 or 7.0.
###end p 49
###begin title 50
Behavior
###end title 50
###begin p 51
All behavioral experiments involving vertebrate animals were approved by the Institutional Animal Care and Use Committee at the University of North Carolina at Chapel Hill.
###end p 51
###begin p 52
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
C57BL/6 male mice, 2-4 months old, were purchased from Jackson Laboratories and used for all behavioral experiments. All mice were acclimated to the testing room, equipment and experimenter for at least three days before behavioral testing. The experimenter was blind to drug treatment during behavioral testing.
###end p 52
###begin p 53
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Hargreaves1">[49]</xref>
###xml 566 570 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Cunha1">[50]</xref>
###xml 572 576 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Inoue1">[51]</xref>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 782 785 <span type="species:ncbi:31658">CFA</span>
###xml 1155 1159 <span type="species:ncbi:10090">mice</span>
Thermal sensitivity was measured by heating one hindpaw with a Plantar Test apparatus (IITC) following the Hargreaves method [49]. The radiant heat source intensity (Plantar test apparatus, IITC) was calibrated so that a paw withdrawal reflex was evoked in approximately10 s., on average, in wild-type C57BL/6 mice. Cutoff time was 20 s. One measurement was taken from each paw per time point to determine paw withdrawal latency. Mechanical sensitivity was measured using semi-flexible tips attached to an Electronic von Frey apparatus (IITC) as described elsewhere [50], [51]. Three measurements were taken from each paw (separated at 10 min intervals) then averaged to determine paw withdrawal threshold in grams. To induce inflammatory pain, 20 microL Complete Freunds Adjuvant (CFA, from MP Biomedicals) was injected into one hindpaw, centrally beneath glabrous skin, with a 30G needle. 8-cyclopentyl-1, 3-dipropylxanthine (C101, Sigma) was dissolved in 0.9% saline containing 5% DMSO, 1.25% 1 M NaOH for i.p. injection. Sedation and motor dysfunction were assessed by visually observing motor activity following injections. None of the mPAP-injected mice displayed reduced mobility or paralysis following injection.
###end p 53
###begin title 54
Intrathecal injections
###end title 54
###begin p 55
###xml 445 449 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004248-Fairbanks1">[52]</xref>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
We used concentrated mPAP protein (in PBS; 1.1 mg/mL; 400 U/mL) or diluted mPAP (in 0.9% saline) for injections. mPAP was heat-inactivated by incubating at 65degreesC for 40 min. Loss of activity was confirmed using the EnzChek Phosphatase Assay Kit (Invitrogen, E12020) following the manufacturer's protocol. Active or heat-inactivated mPAP was intrathecally injected (5 microL) into unanesthetized mice using the direct lumbar puncture method [52].
###end p 55
###begin p 56
###xml 72 73 72 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 282 289 282 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004248-g001">Fig. 1D</xref>
We thank Davin Townley-Tilson and Yvette Chuang for making the mPAP-Tr-H6 clone, Yvette Chuang for excellent technical assistance, Jost Vielmetter and Michael Anaya at the Caltech Protein Expression Center for purifying mPAP protein and for providing the western blot data shown in Fig. 1D.
###end p 56
###begin title 57
References
###end title 57
###begin article-title 58
Cytochemical and physiological properties of sensory and dorsal horn neurons that transmit cutaneous sensation.
###end article-title 58
###begin article-title 59
Thiamine monophosphatase: a genuine marker for transganglionic regulation of primary sensory neurons.
###end article-title 59
###begin article-title 60
Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine.
###end article-title 60
###begin article-title 61
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human prostatic acid phosphatases: purification of a minor enzyme and comparisons of the enzymes.
###end article-title 61
###begin article-title 62
Prostatic acid phosphatase is not a prostate specific target.
###end article-title 62
###begin article-title 63
###xml 21 24 <span type="species:ncbi:10116">rat</span>
Primary structure of rat secretory acid phosphatase and comparison to other acid phosphatases.
###end article-title 63
###begin article-title 64
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Increased nociceptive response in mice lacking the adenosine A1 receptor.
###end article-title 64
###begin article-title 65
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat acid phosphatase: overexpression of active, secreted enzyme by recombinant baculovirus-infected insect cells, molecular properties, and crystallization.
###end article-title 65
###begin article-title 66
###xml 27 32 <span type="species:ncbi:9606">human</span>
Heterologous expression of human prostatic acid phosphatase and site-directed mutagenesis of the enzyme active site.
###end article-title 66
###begin article-title 67
Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.
###end article-title 67
###begin article-title 68
Interferon-alpha in malignant and viral diseases. A review.
###end article-title 68
###begin article-title 69
Growth hormone use in the treatment of idiopathic short stature.
###end article-title 69
###begin article-title 70
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human prostatic acid phosphatase: selected properties and practical applications.
###end article-title 70
###begin article-title 71
###xml 31 34 <span type="species:ncbi:10116">rat</span>
Three-dimensional structure of rat acid phosphatase.
###end article-title 71
###begin article-title 72
Site-directed mutagenesis of prostatic acid phosphatase. Catalytically important aspartic acid 258, substrate specificity, and oligomerization.
###end article-title 72
###begin article-title 73
###xml 34 39 <span type="species:ncbi:9606">human</span>
Characterization of the principal human prostatic acid phosphatase isoenzyme, purified by affinity chromatography and isoelectric focusing. Part II.
###end article-title 73
###begin article-title 74
###xml 12 17 <span type="species:ncbi:9606">human</span>
Activity of human prostatic acid phosphatase toward purine 5'-phosphonucleosides.
###end article-title 74
###begin article-title 75
###xml 37 42 <span type="species:ncbi:9606">human</span>
Specificity of acid phosphatase from human prostate.
###end article-title 75
###begin article-title 76
###xml 26 31 <span type="species:ncbi:9606">human</span>
Biochemical properties of human prostatic acid phosphatase.
###end article-title 76
###begin article-title 77
Molecular mechanisms of nociception.
###end article-title 77
###begin article-title 78
The capsaicin receptor: a heat-activated ion channel in the pain pathway.
###end article-title 78
###begin article-title 79
A proton-gated cation channel involved in acid-sensing.
###end article-title 79
###begin article-title 80
Acid-sensing ion channels (ASICs) and pH in synapse physiology.
###end article-title 80
###begin article-title 81
Physiology and pathophysiology of purinergic neurotransmission.
###end article-title 81
###begin article-title 82
The P2Y agonist UTP activates cutaneous afferent fibers.
###end article-title 82
###begin article-title 83
Adenosine and ATP receptors.
###end article-title 83
###begin article-title 84
Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia.
###end article-title 84
###begin article-title 85
P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury.
###end article-title 85
###begin article-title 86
###xml 69 73 <span type="species:ncbi:10116">rats</span>
Intrathecal administration of ATP produces long-lasting allodynia in rats: differential mechanisms in the phase of the induction and maintenance.
###end article-title 86
###begin article-title 87
Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins.
###end article-title 87
###begin article-title 88
###xml 55 58 <span type="species:ncbi:10116">rat</span>
Extracellular alkaline-acid-alkaline transients in the rat spinal cord evoked by peripheral stimulation.
###end article-title 88
###begin article-title 89
Extracellular pH and stimulated neurons.
###end article-title 89
###begin article-title 90
Modulation of pH by neuronal activity.
###end article-title 90
###begin article-title 91
Clinical application of adenosine and ATP for pain control.
###end article-title 91
###begin article-title 92
###xml 93 96 <span type="species:ncbi:10116">rat</span>
Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain.
###end article-title 92
###begin article-title 93
###xml 52 60 <span type="species:ncbi:9606">patients</span>
The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain.
###end article-title 93
###begin article-title 94
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain.
###end article-title 94
###begin article-title 95
###xml 44 47 <span type="species:ncbi:10116">rat</span>
Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord.
###end article-title 95
###begin article-title 96
Cerebrospinal fluid purine metabolite and neuron-specific enolase concentrations after febrile seizures.
###end article-title 96
###begin article-title 97
The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves.
###end article-title 97
###begin article-title 98
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury.
###end article-title 98
###begin article-title 99
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor.
###end article-title 99
###begin article-title 100
###xml 129 132 <span type="species:ncbi:10116">rat</span>
Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat.
###end article-title 100
###begin article-title 101
Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration.
###end article-title 101
###begin article-title 102
###xml 155 159 <span type="species:ncbi:10116">rats</span>
Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats.
###end article-title 102
###begin article-title 103
Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial.
###end article-title 103
###begin article-title 104
###xml 21 26 <span type="species:ncbi:9606">human</span>
Crystal structure of human prostatic acid phosphatase.
###end article-title 104
###begin article-title 105
An improved assay for nanomole amounts of inorganic phosphate.
###end article-title 105
###begin article-title 106
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia.
###end article-title 106
###begin article-title 107
###xml 54 58 <span type="species:ncbi:10090">mice</span>
An electronic pressure-meter nociception paw test for mice.
###end article-title 107
###begin article-title 108
Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling.
###end article-title 108
###begin article-title 109
Spinal delivery of analgesics in experimental models of pain and analgesia.
###end article-title 109
###begin p 110
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 110
###begin p 111
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by UNC startup funds, grants to M.J.Z. from The Sloan Foundation, The Searle Scholars Program, The Klingenstein Foundation, The Whitehall Foundation, Rita Allen Foundation and NINDS (R01NS060725), a grant to N.A.S. from NINDS (F30NS063507). M.J.Z. is a Rita Allen Foundation Milton E. Cassel Scholar. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
###end p 111

